Inflammatory bowel disease – familial and sporadic form

Česká verzia

Authors: M. Pintér; M. Pintérová Kolesárová; S. Rejchrt; T. Douda; R. Repák; M. Kopáčová; J. Bureš
Authors place of work: II. interní klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MU Dr. Jaroslav Malý, CSc., a Subkatedra gastroenterologie Interní katedry Lékařské fakulty UK Hradec Králové, přednosta prof. MU Dr. Jaroslav Malý, CSc.
Published in the journal: Vnitř Lék 2009; 55(11): 1022-1029
Category: Original Contributions

Summary

The aim:
The aim of this thesis was to elucidate more differences between a familial and sporadic inflammatory bowel disease by comparing certain clinical data. Methods: We assessed 248 patients with inflammatory bowel disease (IBD) observed in 1994– 2004 in the Academic Department of Gastroenterology at the Medical Faculty in Hradec Králové. To get information about the defined characters we obtained from the questionary and the hospital data. Results: We did not identify any relationship between the onset of the disease and a certain age group, yet males seem to be more prone to familial Crohn’s disease. The more frequent familial form of Crohn’s disease was the fibro‑stenotic one. There were no differences in the onset of the disease. We did not prove the differences in extraintestinal signs, alergy and comorbidities. We did not find any differences in therapy response in relation to the type of nutrition (enteral, parenteral) and the administration of immunosupresive drugs. The biological therapy in sporadic and familial Crohn’s disease did not differ either. Surgical intervention was more frequent in Crohn’s patients compared to the patients with ulcerative colitis; yet no difference was identified between familial and sporadic cases. Appendectomy carried out before the onset of the disease was later diagnosed as Crohn’s disease in more instances than ulcerative colitis. Conclusion: We did not prove significant differences comparing certain clinical data in familial and sporadic form of inflammatory bowel disease, yet males seem to be more prone to familial Crohn’s disease. Small bowel was involved more often in familial form of Crohn’s disease than in sporadic form.

Key words:
Crohn’s disease – ulcerative colitis – familial – sporadic

Zdroje

1. Lukáš M. Epidemiologie idiopatických střevních zánětů. 35– 41. In: Lukáš M et al (eds). Idiopatické střevní záněty. Praha: Galén 1998.

2. Bayless TM, Tokayer AZ, Polito JM et al. Crohn’s disease: Concordance for site and clinical type in affected family members – potential hereditary influences. Gastroenterology 1996; 111: 573– 579.

3. Halme L, Paavola- Sakki P, Turunen U et al. Family and twin studies in inflammatory bowel disease. World J Gastroenterol 2006; 12: 3668– 3672.

4. Peeters M, Cortot A, Vermeire S et al. Familial and sporadic inflammatory bowel disease: different entities? Inflamm Bowel Dis 2000; 6: 314– 320.

5. Henriksen M, Jahnsen J, Lygren I et al. Are there any difference in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population‑based follow‑up study. Am J Gastroenterol 2007; 102: 1955– 1963.

6. Yang H, McElree C, Roth MP et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non‑Jews. Gut 1993; 34: 517– 524.

7. Carbonnel F, Macaigne G, Beaugerie L et al. Crohn’s disease severity in familial and sporadic cases. Gut 1999; 44: 91– 95.

8. Nguyen GC, Torres EA, Regueiro M et al. Inflammatory bowel disease characteristic among african americans, hispanics, and non‑hispanic whites: characterisation of a large north american cohort. Am J Gastroenterol 2006; 101: 1012– 1023.

9. Halme L, Turunen U, Heliö T et al. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol 2002; 37: 692– 698.

10. Polito JM, Childs B, Mellits ED et al. Crohn’s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996; 111: 580– 586.

11. Colombel JF, Grandbastien B, Gower‑ Rousseau C et al. Clinical characteristics of Crohn’s disease in 72 families. Gastroenterology 1996; 111: 604– 607.

12. Cottone M, Brignola C, Rosselli M et al. Relationship between site of disease and familial occurrence in Crohn’s disease. Dig Dis Sci 1997; 42: 129– 132.

13. Orchard TR, Chua CN, Ahmad T et al. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 2002; 123: 714– 718.

14. Ricart E, Panaccione R, Loftus EV jr et al. Autoimmune disorders and extraintestinal manifestations in first‑ degree familial and sporadic inflammatory bowel disease: a case‑ control study. Inflamm Bowel Dis 2004; 10: 207– 214.

15. Lakatos L, Mester G, Erdélyi Z et al. Epidemiology of inflammatory bowel disease in Veszprem county of Western Hungary between 1977 and 2001. Orv Hetil 2003; 144: 1819– 1827.

16. Hájek J, Sillinger P, Vyhnálek P et al. Nespecifické střevní záněty v regionu Pardubice. Čes Slov Gastroent Hepatol 2005; 59: 199– 203.

17. Firouzi F, Bahari A, Aghazadeh R et al. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: a case control study in Iran. Int J Colorectal Dis 2006; 21: 155– 159.

18. Reif S, Lavy A, Keter D et al. Appendectomy is more frequent but not a risk factor in Crohn’s disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 829– 832.

19. Andersson RE, Olaison G, Tysk C et al. Appendectomy is followed by increased risk of Crohn’s disease. Gastroenterology 2003; 124: 40– 46.

20. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev 2007; 1: CD000542.

21. Zbořil V. Biologická terapie v gastroenterologii. Čes Slov Gastroent Hepatol 2007; 61: 287– 292.